Terms: = Colorectal cancer AND EPAS1, MOP2, 2034, ENSG00000116016, PASD2, HIF2A, Q99814 AND Prognosis
3 results:
1. Identification of novel mutations and functional impacts of epas1 in colorectal cancer.
Islam F; Gopalan V; Lu CT; Pillai S; Lam AK
Cancer Med; 2021 Aug; 10(16):5557-5573. PubMed ID: 34250767
[TBL] [Abstract] [Full Text] [Related]
2. Combined fibrinogen-to-pre-albumin ratio and carbohydrate antigen 19-9 score is a promising metric to predict progression of metastatic colorectal mucinous adenocarcinoma.
Liao YC; Fu M; Wang XF; Cheng XX
J Clin Lab Anal; 2021 May; 35(5):e23757. PubMed ID: 33734488
[TBL] [Abstract] [Full Text] [Related]
3. HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers.
Baba Y; Nosho K; Shima K; Irahara N; Chan AT; Meyerhardt JA; Chung DC; Giovannucci EL; Fuchs CS; Ogino S
Am J Pathol; 2010 May; 176(5):2292-301. PubMed ID: 20363910
[TBL] [Abstract] [Full Text] [Related]
